HDAC8 inhibitor (Cloud Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHDAC8 inhibitor (Cloud Pharmaceuticals)
Drug Alias NameHDAC8 inhibitor (TeraDiscoveries)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 8 inhibitors
TargetsHistone deacetylase 8
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCloud Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCloud Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell

Other Information

ATC CodeN/A
Related LinksN/A